Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A

Archive ouverte

Lepelley, Alice | Della Mina, Erika | van Nieuwenhove, Erika | Waumans, Lise | Fraitag, Sylvie | Rice, Gillian | Dhir, Ashish | Frémond, Marie-Louise | Rodero, Mathieu P | Seabra, Luis | Carter, Edwin | Bodemer, Christine | Buhas, Daniela | Callewaert, Bert | de Lonlay, Pascale | de Somer, Lien | Dyment, David | Faes, Fran | Grove, Lucy | Holden, Simon | Hully, Marie | Kurian, Manju | Mcmillan, Hugh | Suetens, Kristin | Tyynismaa, Henna | Chhun, Stéphanie | Wai, Timothy | Wouters, Carine | Bader-Meunier, Brigitte | Crow, Yanick

Edité par CCSD ; Rockefeller University Press -

International audience. Mitochondrial DNA (mtDNA) has been suggested to drive immune system activation, but the induction of interferon signaling by mtDNA has not been demonstrated in a Mendelian mitochondrial disease. We initially ascertained two patients, one with a purely neurological phenotype and one with features suggestive of systemic sclerosis in a syndromic context, and found them both to demonstrate enhanced interferon-stimulated gene (ISG) expression in blood. We determined each to harbor a previously described de novo dominant-negative heterozygous mutation in ATAD3A, encoding ATPase family AAA domain-containing protein 3A (ATAD3A). We identified five further patients with mutations in ATAD3A and recorded up-regulated ISG expression and interferon α protein in four of them. Knockdown of ATAD3A in THP-1 cells resulted in increased interferon signaling, mediated by cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Enhanced interferon signaling was abrogated in THP-1 cells and patient fibroblasts depleted of mtDNA. Thus, mutations in the mitochondrial membrane protein ATAD3A define a novel type I interferonopathy.

Suggestions

Du même auteur

cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing

Archive ouverte | Uggenti, Carolina | CCSD

International audience. Inappropriate stimulation or defective negative regulation of the type I interferon response can lead to autoinflammation. In genetically uncharacterized cases of the type I interferonopathy ...

Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies

Archive ouverte | Lodi, Lorenzo | CCSD

International audience. Whilst upregulation of type I interferon (IFN) signaling is common across the type I interferonopathies (T1Is), central nervous system (CNS) involvement varies between these disorders, the ba...

Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation

Archive ouverte | Triaille, Clément | CCSD

International audience. Hereditary C1q deficiency (C1QDef) is a rare monogenic disorder leading to defective complement pathway activation and systemic lupus erythematosus (SLE)-like manifestations. The link between...

Chargement des enrichissements...